Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoë Johnson

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Pharmaceuticals (Basel, Switzerland)|August 10, 2017
Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex SystemAmanda E I Proudfoot, Zoë Johnson, Pauline Bonvin, et al.
Immunology|January 25, 2011
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytesAnna Korniejewska, Andrew J McKnight, Zoë Johnson, et al.
Blood|May 24, 2003
Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endotheliumThomas Baltus, Kim S C Weber, Zoë Johnson, et al.
Trends in Immunology|May 4, 2005
Multi-faceted strategies to combat disease by interference with the chemokine systemZoë Johnson, Matthias Schwarz, Christine A Power, et al.
Journal of Immunological Methods|November 17, 2006
Quantitative detection of therapeutic proteins and their metabolites in serum using antibody-coupled ProteinChip Arrays and SELDI-TOF-MSLinda Favre-Kontula, Zoë Johnson, Tiana Steinhoff, et al.
The FEBS Journal|August 6, 2013
Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease modelsMaud Déruaz, Pauline Bonvin, India C Severin, et al.
Molecular Immunology|June 16, 2009
The basic residue cluster (55)KKWVR(59) in CCL5 is required for in vivo biologic functionStephan Segerer, Zoë Johnson, Angelika Rek, et al.
Structure (London, England : 1993)|November 9, 2004
The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitorsJeffrey P Shaw, Zoë Johnson, Frédéric Borlat, et al.
The Journal of Biological Chemistry|March 23, 2004
Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivoElaine K Lau, Chad D Paavola, Zoë Johnson, et al.
The Journal of Biological Chemistry|April 6, 2010
Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycansIndia C Severin, Jean-Philippe Gaudry, Zoë Johnson, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|August 10, 2017
Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex SystemAmanda E I Proudfoot, Zoë Johnson, Pauline Bonvin, et al.
Immunology|January 25, 2011
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytesAnna Korniejewska, Andrew J McKnight, Zoë Johnson, et al.
Blood|May 24, 2003
Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endotheliumThomas Baltus, Kim S C Weber, Zoë Johnson, et al.
Trends in Immunology|May 4, 2005
Multi-faceted strategies to combat disease by interference with the chemokine systemZoë Johnson, Matthias Schwarz, Christine A Power, et al.
Journal of Immunological Methods|November 17, 2006
Quantitative detection of therapeutic proteins and their metabolites in serum using antibody-coupled ProteinChip Arrays and SELDI-TOF-MSLinda Favre-Kontula, Zoë Johnson, Tiana Steinhoff, et al.
The FEBS Journal|August 6, 2013
Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease modelsMaud Déruaz, Pauline Bonvin, India C Severin, et al.
Molecular Immunology|June 16, 2009
The basic residue cluster (55)KKWVR(59) in CCL5 is required for in vivo biologic functionStephan Segerer, Zoë Johnson, Angelika Rek, et al.
Structure (London, England : 1993)|November 9, 2004
The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitorsJeffrey P Shaw, Zoë Johnson, Frédéric Borlat, et al.
The Journal of Biological Chemistry|March 23, 2004
Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivoElaine K Lau, Chad D Paavola, Zoë Johnson, et al.
The Journal of Biological Chemistry|April 6, 2010
Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycansIndia C Severin, Jean-Philippe Gaudry, Zoë Johnson, et al.
Pageof 3